drugset / Trial / NCT01005147
Effect of Tranexamic Acid in Upper Gastrointestinal Bleeding
Withdrawn
University of Oklahoma
RandomizedParallel-groupTriple-blindTreatment
Summary
The investigators hypothesize that addition of Tranexamic acid, an antifibrinolytic agent, to conventional therapy will lead to an improved outcome characterized by lower transfusion requirements.
Timeline
- Start
- 2009-11
- Primary completion
- —
- Completion
- 2011-10
Outcome
Outcome not reported
Stopped (Enrollment): “No participants enrolled”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tranexamic Acid | Small molecule | 5 mg/kg | Intravenous |
| Subject | Tranexamic Acid | Small molecule | 10 mg/kg | Intravenous |
| Subject | Tranexamic Acid | Small molecule | 1 g | Intravenous |
Indications
No indication recorded.